Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 CAD | -1.99% | +7.66% | +168.18% |
05-14 | Cardiol Therapeutics Says Phase II ARCHER Trial Presented at World Congress on Acute Heart Failure | MT |
04-22 | HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+168.18% | 150M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- CRDL Stock
- News Cardiol Therapeutics Inc.
- HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target